Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
eNrNWF1v2jAUfedXRHl3ApRCOgWqjbUbUqsyWrRpL5VJboqZsVN/UNpfP4fQjU7J2ppa6gsScXLuje+55544Pl4vqbcCIQlnfb8VNH0PWMJTwm76/vTqFEX+8aARL/AK79zWC5pBq+17CcVS9v1iNZgBZjL4cX72GczzIPxBw4v5bAGJenKfVoQGX7Gcn+O8uMeLV5yk3hLUnKd9P9dqc9WLpRImi8EdF79kjhOIw+2V3dXFdWf3ehwWYC9A1RLEGWY3laCZsMJMtBDA1BAruOHivho6uW5HvW6zGVmFIHICkmuRwBir+VjwFUkhrY6EqQSrINldegliRUEVQSrBw0WylFbgeIHXE7gdVSf90awO1VqhJmr1up3e4cFR9+jwqGsVSuxsVTV5zEuE+fVBq9XudFthJsIcPwAjAhm+UaLwGihKDa2RZoAyLpaaYmVaAKWAGGY8x0KRRFOQiBIwvxhRhOlMLwkDywKPuVCYOiotkcOnJHUUR8DtsxRKicwpvg8WMrfdKiywWQZhpMTdixRvcCUMC0zt/8VnmtLwlVlPt9LjKONC2YZcM1WjQKcT240YcqZgXV9RO9FU6y0XCci3g33grHpgjPWMksRWF41yaZBqOhnVy+K7U5RPWMJUuJOU74Sl/E6+vVTtUsNR9vlGbf8zqjtRFFn34U/DwppJd6IFzyE0EkbkPso0YhnfV5MMsauhHmn9vhi98W48wRRq3Buy1DhD5Uez6axZ3DViuVAJ+uXkypZj3zSI+8vN30pokvb/sMNuALiYKobRtYm/vj9KkXiBr+9EB207SotqDZorlcsPYTjHEklsNiowDfguh8yOOXD3WeLEgZSOrJRqR6nPygn88hLbdutz/mRfz719fuvtK2MooWGPOpTC7kx+Rydvr+h/DbeztMdPFMhdmI053miFK7+lZ5WI+80QU1d2Kow4XGQZqTkpquVlHJanVINGHBYnVIPGb2uqTiw=
KUN9eTt6A2U73ShV